Morphic Announces Appointment of Peter G. Linde, M.D., as Chief Medical Officer
March 17, 2020 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
IMARA Announces Pricing of Initial Public Offering
March 11, 2020 21:57 ET
|
Imara, Inc.
BOSTON, March 11, 2020 (GLOBE NEWSWIRE) -- IMARA Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to...
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2019
February 27, 2020 16:05 ET
|
Morphic Therapeutic
WALTHAM, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
Big3Bio Announces Upcoming Launch of Philadelphia as a New Region of Coverage; Will Rebrand as Big4Bio
March 05, 2019 07:26 ET
|
Big3Bio
- Big4Bio:Philly to Recap Life Science Developments in the Greater Philadelphia Region; To Launch During BIO International Convention in Philadelphia in June- All “Big3Bio” Regional Sites of Boston,...